208 related articles for article (PubMed ID: 32317748)
1. Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia-a randomized controlled trial.
Xu Z; Xie J; Zhang H; Pang J; Li Q; Wang X; Xu H; Sun X; Zhao H; Yang Y; Ling W
Eur J Clin Nutr; 2021 Feb; 75(2):345-354. PubMed ID: 32317748
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent reductions in plasma ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux capacity in dyslipidemia: A randomized controlled trial.
Zhao Y; Xu H; Tian Z; Wang X; Xu L; Li K; Gao X; Fan D; Ma X; Ling W; Yang Y
Clin Nutr; 2021 Apr; 40(4):1871-1878. PubMed ID: 33131908
[TBL] [Abstract][Full Text] [Related]
3. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects.
Qin Y; Xia M; Ma J; Hao Y; Liu J; Mou H; Cao L; Ling W
Am J Clin Nutr; 2009 Sep; 90(3):485-92. PubMed ID: 19640950
[TBL] [Abstract][Full Text] [Related]
4. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.
Zhu Y; Huang X; Zhang Y; Wang Y; Liu Y; Sun R; Xia M
J Clin Endocrinol Metab; 2014 Feb; 99(2):561-9. PubMed ID: 24285687
[TBL] [Abstract][Full Text] [Related]
5. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
Li D; Zhang Y; Liu Y; Sun R; Xia M
J Nutr; 2015 Apr; 145(4):742-8. PubMed ID: 25833778
[TBL] [Abstract][Full Text] [Related]
6. Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose-response manner in subjects with dyslipidemia.
Zhang H; Xu Z; Zhao H; Wang X; Pang J; Li Q; Yang Y; Ling W
Redox Biol; 2020 May; 32():101474. PubMed ID: 32179241
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of anthocyanin supplementation on platelet function in subjects with dyslipidemia: A randomized clinical trial.
Tian Z; Li K; Fan D; Zhao Y; Gao X; Ma X; Xu L; Shi Y; Ya F; Zou J; Wang P; Mao Y; Ling W; Yang Y
EBioMedicine; 2021 Aug; 70():103533. PubMed ID: 34392146
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia.
Zou J; Tian Z; Zhao Y; Qiu X; Mao Y; Li K; Shi Y; Zhao D; Liang Y; Ji Q; Ling W; Yang Y
Nutrition; 2022 Sep; 101():111703. PubMed ID: 35700592
[TBL] [Abstract][Full Text] [Related]
9. Cuban policosanol improves high-density lipoprotein cholesterol efflux capacity in healthy Japanese subjects.
Uehara Y; Komatsu T; Sasaki K; Abe S; Nakashima S; Yamamoto T; Kim JE; Cho KH
Front Nutr; 2023; 10():1297008. PubMed ID: 38260075
[TBL] [Abstract][Full Text] [Related]
10. Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.
Curtis PJ; Berends L; van der Velpen V; Jennings A; Haag L; Chandra P; Kay CD; Rimm EB; Cassidy A
Clin Nutr; 2022 Jan; 41(1):165-176. PubMed ID: 34883305
[TBL] [Abstract][Full Text] [Related]
11. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
[TBL] [Abstract][Full Text] [Related]
14. Effects of Anthocyanin on Serum Lipids in Dyslipidemia Patients: A Systematic Review and Meta-Analysis.
Liu C; Sun J; Lu Y; Bo Y
PLoS One; 2016; 11(9):e0162089. PubMed ID: 27589062
[TBL] [Abstract][Full Text] [Related]
15. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals.
Zhu Y; Xia M; Yang Y; Liu F; Li Z; Hao Y; Mi M; Jin T; Ling W
Clin Chem; 2011 Nov; 57(11):1524-33. PubMed ID: 21926181
[TBL] [Abstract][Full Text] [Related]
16. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
[TBL] [Abstract][Full Text] [Related]
18. Effects of Dietary Education Program for the Japan Diet on Cholesterol Efflux Capacity: A Randomized Controlled Trial.
Umezawa A; Maruyama C; Endo Y; Suenaga Y; Shijo Y; Kameyama N; Sato A; Nishitani A; Ayaori M; Waki M; Teramoto T; Ikewaki K
J Atheroscler Thromb; 2022 Jun; 29(6):881-893. PubMed ID: 34024872
[TBL] [Abstract][Full Text] [Related]
19. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
[TBL] [Abstract][Full Text] [Related]
20. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
Furuyama F; Koba S; Yokota Y; Tsunoda F; Shoji M; Kobayashi Y
J Atheroscler Thromb; 2018 Feb; 25(2):153-169. PubMed ID: 28855433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
